MDS Translation Program for MDS-UPDRS, UDysRS, and MDS-NMS
Objective: To summarize the status of the ongoing MDS-sponsored translation programs for non-English versions of the MDS-UPDRS, UDysRS, and MDS-NMS. Background: The MDS-UPDRS, UDysRS, and…Cognitive-driven ADL impairment as a predictor for PDD
Objective: To evaluate whether Parkinson’s disease (PD) patients with mild activity of daily living (ADL) impairment are at higher risk for developing dementia (PDD). Background:…Maximising UPDRS information while minimising assessment time
Objective: The gold standard for measuring disease severity in PD (Parkinson’s Disease) is the MDS-UPDRS (Movement Disorder Society - Unified PD Rating Scale) [1]. However,…Prognostic Modeling of Parkinson’s Disease Progression Using Early Longitudinal Patterns of Change
Objective: To develop a prognostic model using multiple longitudinal measures to predict temporal clinical progression in early PD. Background: Predicting time to Parkinson’s disease (PD)…Development of the Parkinson’s Disease Medication Adherence Scale (PD-MAS)
Objective: To implement the first 3 phases of the scale development process that will create the PD-MAS. Background: Drug therapy is a central strategy in…Building a Global Parkinson’s Genetics Program (GP2): Clinical Cohorts Integration Working Group
Objective: To recruit Parkinson's Disease (PD) cohorts across the world for the global Parkinson's Genetics Program (GP2, http://gp2.org/), harmonise clinical data across cohorts for joint…Fragile X-Associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS): development process using the Delphi method
Objective: To develop a revised and improved version of the FXTAS-RS. Background: Accurate measurement of FXTAS motor symptoms is vital to provide valid and reliable…Predictors of Clinically Significant Quality of Life Impairment in Parkinson´s Disease. Results from the COPPADIS Cohort at 2 Years Follow-up.
Objective: The aim of the present study was to identify predictors of clinically significant quality of life (QoL) impairment in Parkinson´s disease (PD) patients from…The comparisons between UPDRS and MDS-UPDRS in evaluating motor dysfunctions after subthalamic nucleus deep brain stimulation
Objective: We aimed to examine whether MDS-UPDRS are able to detect longitudinal changes in motor functions after STN-DBS in comparison to UPDRS. Background: Although MDS-UPDRS…Using smartphone data to infer social behaviour in Parkinson’s: proof of principle and the impact of COVID19
Objective: To investigate the potential of using smartphone data to infer changes in social behaviour in people with Parkinson's and how this has been impacted…
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 32
- Next Page »